Evidence map›Paper›PMID 29301504›Full record

ArticleBMC cancer2018

Nine primary malignant neoplasms-involving the esophagus, stomach, colon, rectum, prostate, and external ear canal-without microsatellite instability: a case report.

Keiichi Arakawa, Keisuke Hata, Yoko Yamamoto, Takeshi Nishikawa, Toshiaki Tanaka, Tomomichi Kiyomatsu, Kazushige Kawai, Hiroaki Nozawa, Masafumi Yoshida, Hiroshi Fukuhara and 6 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Keiichi ArakawaDepartment of Surgical Oncology, the University of Tokyo, Tokyo, Japan. keiichiarakawa@hotmail.com.
Keisuke HataDepartment of Surgical Oncology, the University of Tokyo, Tokyo, Japan.
Yoko YamamotoDepartment of Surgical Oncology, the University of Tokyo, Tokyo, Japan.
Takeshi NishikawaDepartment of Surgical Oncology, the University of Tokyo, Tokyo, Japan.
Toshiaki TanakaDepartment of Surgical Oncology, the University of Tokyo, Tokyo, Japan.
Tomomichi KiyomatsuDepartment of Surgical Oncology, the University of Tokyo, Tokyo, Japan.
Kazushige KawaiDepartment of Surgical Oncology, the University of Tokyo, Tokyo, Japan.
Hiroaki NozawaDepartment of Surgical Oncology, the University of Tokyo, Tokyo, Japan.
Masafumi YoshidaDepartment of Otolaryngology, the University of Tokyo, Tokyo, Japan.
Hiroshi FukuharaDepartment of Urology, the University of Tokyo, Tokyo, Japan.
Mitsuhiro FujishiroDepartment of Gastroenterology, the University of Tokyo, Tokyo, Japan.
Teppei MorikawaDepartment of Pathology, the University of Tokyo, Tokyo, Japan.
Tatsuya YamasobaDepartment of Otolaryngology, the University of Tokyo, Tokyo, Japan.
Kazuhiko KoikeDepartment of Gastroenterology, the University of Tokyo, Tokyo, Japan.
Masashi FukayamaDepartment of Pathology, the University of Tokyo, Tokyo, Japan.
Toshiaki WatanabeDepartment of Surgical Oncology, the University of Tokyo, Tokyo, Japan.
The University of Tokyo · JPUniversity of Tokyo Hospital · JP

Funding

Japan Society for the Promotion of Science 16H02672Japan Society for the Promotion of Science 16K07143Japan Society for the Promotion of Science 16K07161Japan Society for the Promotion of Science 17K10620Japan Society for the Promotion of Science 17K10621
6 · The paper itself

Abstract

backgroundAlthough cases of multiple primary malignant neoplasms are increasing, reports of more than three or four primary metachronous malignant neoplasms are extremely rare. Moreover, very few publications have provided a genetic mutational analysis or have evaluated risk factors associated with such neoplasms. We present an extremely rare case of nine primary malignant lesions in a man who was successfully treated. We also report on microsatellite stability status, analyze risk factors, and discuss the relevant literature. CASE PRESENTATION: Between 67 and 73 years of age, a male patient developed nine primary metachronous malignant lesions: Three were located in the esophagus, two in the stomach, two in the colorectum, one in the prostate gland, and one in the external ear canal. The patient's clinical history included hypertension, atrial fibrillation, an acoustic schwannoma, and heavy smoking. The lesions were diagnosed during regular screening over a six-year period. He was successfully treated with surgery (both open surgical and endoscopic resection of lesions) and adjuvant chemotherapy. Immunohistochemistry and mutational analysis showed that the lesions were microsatellite stable, and the KRAS, BRAF, p53, and nuclear β-catenin status was not uniform among the lesions.

conclusionsGiven that the presence of more than three or four neoplasms is extremely rare, the present case of nine primary malignancies with no associated microsatellite instability and no apparent predisposing hereditary conditions, is extraordinary. Our case study shows that it is possible for up to nine sporadic neoplasms to occur, and efficient disease management requires diligent screening and early detection.

Indexed as

AgedChemotherapy, AdjuvantColorectal NeoplasmsEar CanalEsophagusHumansMaleMicrosatellite InstabilityNeoplasms, Multiple PrimaryNeoplasms, Second PrimaryProstateStomachColorectal neoplasmsMicrosatellite instabilityMultiple primary neoplasms

Identifiers

PMID29301504
PMCPMC5753511
OpenAlexW2781571072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.